List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 18 studies with search of: " March 31, 2007":" April 30, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
Conditions: HIV-Dementia;   HIV-Associated Cognitive Motor Complex;   AIDS Encephalopathy;   AIDS Dementia Complex;   AIDS-Related Dementia Complex;   HIV Infections;   Healthy
Intervention: Drug: [11C]PBR28
2 Active, not recruiting Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
Conditions: HIV Infections;   Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome Virus;   AIDS Virus
Intervention: Drug: darunavir (DRV, TMC114)
3 Recruiting Therapeutic Approaches to HAART-Induced Lipodystrophy
Conditions: HIV Infections;   Lipodystrophy
Interventions: Drug: leptin;   Drug: Fish Oil Capsules;   Behavioral: Exercise therapy with dietary advice;   Behavioral: Diet : High cis-monounsaturated fat diet vs. High CHO diet
4 Recruiting Isoniazid Plus (Highly Active Antiretroviral Therapy) HAART to Prevent Tuberculosis (TB) in HIV-Infected Persons
Conditions: Tuberculosis;   Latent Tuberculosis Infection;   HIV Infections
Interventions: Drug: isoniazid;   Drug: Placebo
5 Recruiting Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Placebo
6 Completed HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-Infected Persons
Conditions: HIV Infections;   Herpes Simplex;   Sexually Transmitted Diseases
Interventions: Drug: Valacyclovir;   Drug: Matching Placebo
7 Active, not recruiting Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses
Condition: HIV Infections
Interventions: Drug: raltegravir potassium;   Drug: darunavir/ritonavir;   Drug: etravirine;   Drug: Optimized background regimen
8 Completed LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
Conditions: HIV Infections;   Diffuse Large B Cell Lymphoma
Interventions: Drug: R-CHOP;   Drug: Highly active antiretroviral therapy;   Drug: Central nervous system (CNS) prophylaxis;   Drug: Prophylaxis of opportunistic infections and support treatment
9 Completed Mechanisms of Lipodystrophy in HIV-Infected Pateints
Condition: HIV Infections
Intervention: Drug: Viracept versus Sustiva with stavudine and epivir
10 Recruiting The Treatment of Insomnia in Patients With HIV Disease
Conditions: HIV Infections;   Insomnia
Interventions: Drug: Doxepin;   Drug: Temazepam;   Drug: Placebo
11 Completed Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products
Condition: HIV Infections
Intervention: Drug: nevirapine, stavudine, lamivudine
12 Recruiting Subclinical Atherosclerosis in HIV-infected Men
Conditions: HIV Infections;   Coronary Atherosclerosis
Intervention:
13 Recruiting HIV and Cardiovascular Risk
Conditions: HIV Infections;   Cardiovascular Disease
Intervention:
14 Active, not recruiting Safety of and Immune Response to a Meningitis Vaccine in HIV Infected Children and Youth
Conditions: HIV Infections;   Meningitis
Intervention: Biological: Quadrivalent meningococcal conjugate vaccine (MCV4)
15 Completed CMV Disease and IRIS in HIV-1 Infected Persons
Conditions: HIV Infections;   Cytomegalovirus
Intervention: Genetic: IE gene
16 Terminated ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Antiretroviral therapy
17 Completed Adherence, Efficacy and Tolerance of Once-a-Day Nevirapine-Based Regimen in HIV-1 Infected Patients
Condition: HIV Infections
Intervention: Behavioral: Nevirapine from twice-a-day to once-a-day
18 Completed
Has Results 		Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.
Condition: HIV
Intervention: Drug: TMC125, Darunavir; Ritonavir

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services